External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients

• Joanna Szkandera,

  Affiliation Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria

  ⨯
• Michael Stotz,

  Affiliation Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria

  ⨯
• Florian Eisner,

  Affiliation Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria

  ⨯
• Gudrun Absenger,

  Affiliation Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria

  ⨯
• Tatjana Stojakovic,

  Affiliation Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria

  ⨯
• Hellmut Samonigg,

  Affiliation Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria

  ⨯
• Peter Kornprat,

  Affiliation Division of General Surgery, Department of Surgery, Medical University of Graz, Graz, Austria

  ⨯
• Renate Schaberl-Moser,

  Affiliation Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria

  ⨯
• Wael AlZoughbi,

  Affiliation Institute of Pathology, Medical University of Graz, Graz, Austria

  ⨯
• Anna Lena Ress,

  Affiliation Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria

  ⨯
• Friederike Sophia Seggewies,

  Affiliation Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria

  ⨯
• Armin Gerger,

  Affiliation Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria

  ⨯
• Gerald Hoefler,

  Affiliation Institute of Pathology, Medical University of Graz, Graz, Austria

  ⨯
• Martin Pichler

  * E-mail: martin.pichler@medunigraz.at

  Affiliation Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria

  ⨯